| Entry |
|
|---|
| Name |
Anisotropine methylbromide (USAN);
Octatropine methylbromide (INN);
Methyloctatropine bromide (JAN);
Valpin (TN);
Valpin 50 (TN) |
|---|
| Formula |
C17H32NO2. Br
|
|---|
| Exact mass |
361.1616
|
|---|
| Mol weight |
362.3455
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antispasmodic, Muscarinic acetylcholine receptor antagonist |
|---|
| Comment |
Tropane derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Anisotropine methylbromide
D00232 Anisotropine methylbromide (USAN)
Methyloctatropine
D00232 Anisotropine methylbromide (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
D00232 Anisotropine methylbromide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D00232 Anisotropine methylbromide (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 C1y C 24.3161 -18.7260
2 N2y N 23.2915 -18.1786 #+
3 C1x C 25.8000 -18.7260
4 C1x C 23.1680 -19.7506
5 C1y C 24.1807 -19.7506
6 C1y C 26.8128 -19.8565
7 C1x C 23.1680 -21.0815
8 C1x C 25.3997 -19.4503
9 O7a O 27.4370 -21.0047
10 C7a C 28.7499 -21.0335
11 C1c C 29.4214 -19.9146
12 O6a O 29.3743 -22.1816
13 C1b C 30.7286 -19.8799
14 C1b C 28.7972 -18.7722
15 C1b C 31.4116 -18.7612
16 C1b C 29.4802 -17.6535
17 C1a C 32.7189 -18.7897
18 C1a C 28.8503 -16.5051
19 C1a C 22.2575 -17.1689
20 C1a C 22.1636 -19.0469
21 X Br 23.7867 -15.7350 #-
BOND 21
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 5 8 1
8 6 9 1 #Down
9 9 10 1
10 10 11 1
11 10 12 2
12 11 13 1
13 11 14 1
14 13 15 1
15 14 16 1
16 15 17 1
17 16 18 1
18 5 7 1
19 6 8 1
20 2 19 1
21 2 20 1
|
|---|
